YDL183C Antibody

What is YDL183C and what cellular functions is it associated with?

YDL183C is a Saccharomyces cerevisiae gene encoding a protein involved in maintaining mitochondrial functionality. Based on current research, this protein potentially forms an active mitochondrial potassium-hydrogen exchange (KHE) system that is critical for cellular stress response mechanisms. YDL183C has been identified among upregulated genes involved in maintaining mitochondrial functionality and stabilization during oxidative stress conditions. The gene shows a significant fold change (2.141) in DaMDHAR-expressing transgenic yeast cells compared to wild-type cells, suggesting its importance in redox homeostasis pathways . YDL183C expression is closely connected to other mitochondrial genes in genetic network analyses, indicating integrated functions within mitochondrial systems rather than isolated activity.

How is YDL183C expression regulated under stress conditions?

YDL183C expression is significantly upregulated under oxidative stress conditions, particularly in response to freeze-thaw (FT) stress. In transgenic yeast cells expressing DaMDHAR (monodehydroascorbate reductase), YDL183C showed a 2.141-fold increase compared to wild-type cells . This upregulation occurs alongside other mitochondrial genes, suggesting coordinated regulation as part of cellular stress response pathways. The transcriptional activation appears to be mediated through stress-responsive transcription factors like MSN4, which was also upregulated (2.061-fold) in the same experimental conditions . Interestingly, YDL183C upregulation correlates with enhanced oxidative stress tolerance and mitochondrial function preservation, indicating it plays a protective role under cellular stress.

What is the relationship between YDL183C and other mitochondrial proteins?

YDL183C functions within a network of mitochondrial proteins that collectively maintain mitochondrial integrity during stress conditions. Genetic network analysis reveals that YDL183C operates alongside other upregulated mitochondrial genes including ALD4, CRC1, FMP45, GEM1, NDE2, MRS4, SCM4, DPI8, MBR1, ISU1, MIN3, MAM3, SHH4, and MPC3 . These proteins collaborate to maintain mitochondrial structure and function, with particularly strong functional connections to proteins involved in redox homeostasis and metabolite transport. STRING-GO analysis positions YDL183C within a stress-responsive gene network that includes genes like FMP16, PHM7, MSC1, NQM1, CTT1, and ALD3, which form the central core of genetic interactions responding to oxidative stress .

What are the key considerations for developing effective YDL183C antibodies?

Developing effective YDL183C antibodies requires careful attention to several factors. First, epitope selection should target unique, accessible regions of the YDL183C protein that don't share homology with related proteins. Since YDL183C is a mitochondrial protein, researchers should consider its membrane association and potential conformational epitopes. Second, the expression system used for antigen production significantly impacts antibody quality. For mitochondrial proteins like YDL183C, bacterial expression systems may produce misfolded proteins lacking proper post-translational modifications. Eukaryotic expression systems may yield more native-like antigens. Third, validation protocols must include multiple techniques including Western blotting with proper controls including knockout/null mutants. When developing YDL183C antibodies, researchers should analyze sequence homology with related proteins to ensure specificity, particularly with other mitochondrial KHE system proteins that may share structural similarities.

What validation methods are recommended for YDL183C antibodies?

A comprehensive validation approach for YDL183C antibodies should include multiple orthogonal techniques:

• Western blotting: Using total protein extraction methods as described in the literature (20 μg total protein resolved on SDS-PAGE and transferred to PVDF membrane, blocked with 5% non-fat milk in TBST) . Critical controls should include YDL183C deletion strains.

• Immunoprecipitation: To confirm antibody recognition of native YDL183C and identify interaction partners within the mitochondrial network.

• Subcellular fractionation: To confirm mitochondrial localization of the detected protein, particularly important since YDL183C is part of mitochondrial functionality networks .

• Cross-reactivity testing: Against related mitochondrial proteins to ensure specificity.

• Signal peptide analysis: For confirming proper targeting to mitochondria.

For quantitative applications, researchers should establish standard curves using purified recombinant YDL183C protein to ensure linearity of detection across relevant concentration ranges.

How can I address potential cross-reactivity issues with YDL183C antibodies?

Cross-reactivity is a significant concern with mitochondrial proteins due to conserved domains and shared motifs. To address this issue with YDL183C antibodies, implement the following strategies:

• Computational analysis: Before antibody development, conduct thorough sequence alignment analysis to identify unique regions of YDL183C with minimal homology to other proteins.

• Pre-absorption controls: Pre-incubate antibodies with recombinant YDL183C protein before immunoblotting to verify that binding is abolished, confirming specificity.

• Multiple antibody validation: Develop antibodies against different epitopes of YDL183C and compare their detection patterns.

• Genetic knockout validation: The most conclusive validation utilizes yeast YDL183C deletion strains (ydl183c∆) as negative controls in all detection methods.

• Cross-species reactivity testing: If the antibody is claimed to recognize homologs across species, validate across those species with appropriate controls.

For mitochondrial KHE system proteins specifically, attention should be paid to potential cross-reactivity with other mitochondrial transporters that may share structural motifs with YDL183C.

What are the optimal conditions for using YDL183C antibodies in Western blotting?

Based on established protocols for mitochondrial proteins similar to YDL183C, the following optimized Western blotting conditions are recommended:

• Sample preparation: Extract total protein using mechanical disruption (e.g., glass beads) in a buffer containing protease inhibitors. Centrifuge at 13,000× g for 20 min at 4°C and collect supernatant as protein extract .

• Protein quantification: Determine concentration using protein dye reagent (Bio-Rad) with bovine serum albumin as standard .

• Gel electrophoresis: Resolve 20 μg total protein on 10-12% SDS-PAGE gels .

• Transfer conditions: Electrophoretically transfer to PVDF membrane at 100V for 60-90 minutes in cold transfer buffer containing 20% methanol.

• Blocking: Incubate membrane with blocking buffer containing 5% non-fat skim milk in Tris-buffered saline with 0.05% Tween-20 (TBST) plus 0.02% sodium azide for 1.5 h at 25°C .

• Primary antibody incubation: Dilute anti-YDL183C antibody 1:1000-1:5000 in blocking buffer without sodium azide and incubate overnight at 4°C .

• Washing: Wash four times every 10 min for 40 min total with TBST .

• Secondary antibody: Incubate with appropriately diluted HRP-conjugated secondary antibody for 1.5 h at 25°C .

• Detection: Visualize using ECL Western blotting detection reagent after thorough washing .

• Controls: Include anti-tubulin antibody as loading control and lysate from ydl183c∆ strain as negative control.

How can YDL183C antibodies be used to investigate stress response mechanisms?

YDL183C antibodies can be strategically employed to investigate stress response mechanisms through several approaches:

• Time-course expression analysis: Monitor YDL183C protein levels during exposure to various stressors including oxidative stress (H₂O₂), freeze-thaw stress, and heat shock. This reveals temporal dynamics of YDL183C induction during stress response .

• Subcellular redistribution: Use immunofluorescence microscopy with YDL183C antibodies to track potential redistribution within mitochondrial subcompartments during stress.

• Post-translational modification profiling: Employ YDL183C antibodies in combination with phospho-specific or other PTM-specific detection methods to identify stress-induced modifications.

• Co-immunoprecipitation studies: Use YDL183C antibodies to pull down protein complexes under normal versus stress conditions to identify stress-specific interaction partners within the genetic network identified through transcriptomic analyses .

• Chromatin immunoprecipitation: If YDL183C has potential nuclear functions, ChIP assays with YDL183C antibodies can identify potential DNA-binding activities under stress.

• Correlation with metabolic parameters: Combine YDL183C detection with measurements of NADPH levels and redox status, as these have been shown to change alongside mitochondrial protein expression during stress responses .

This multifaceted approach leverages YDL183C antibodies to build a comprehensive understanding of mitochondrial stress response mechanisms.

What sample preparation techniques are optimal for detecting YDL183C in complex samples?

Detecting YDL183C in complex biological samples requires careful optimization of sample preparation:

• Mitochondrial enrichment: Since YDL183C is a mitochondrial protein, enrichment of mitochondrial fractions significantly improves detection sensitivity. Use differential centrifugation followed by density gradient purification for highest purity.

• Membrane protein extraction: As a potential membrane protein forming part of a KHE system , YDL183C may require specialized extraction methods using mild detergents (0.5-1% digitonin or 0.1% DDM) to maintain native conformation.

• Protein-protein interaction preservation: For co-immunoprecipitation studies, crosslinking with formaldehyde (0.1-1%) prior to extraction can preserve transient interactions within the mitochondrial network.

• Protease inhibitor cocktail: Include a comprehensive protease inhibitor cocktail containing PMSF (1mM), leupeptin (10μg/ml), pepstatin A (1μg/ml), and EDTA (1mM) to prevent degradation.

• Phosphatase inhibitors: Include sodium fluoride (10mM) and sodium orthovanadate (1mM) to preserve phosphorylation states if studying stress-induced PTMs.

• Sample buffer optimization: Use sample buffers with reducing agents (DTT or β-mercaptoethanol) freshly added before SDS-PAGE to maintain consistent detection.

• Subcellular fractionation validation: Confirm fraction purity using established markers (e.g., anti-tubulin for cytosolic fraction, anti-porin for mitochondrial outer membrane) .

For particularly challenging samples, consider using FFPE (formalin-fixed paraffin-embedded) extraction protocols adapted for yeast cells if working with archived samples.

How does YDL183C function change in response to oxidative stress conditions?

YDL183C function undergoes significant changes during oxidative stress that reflect its role in mitochondrial homeostasis:

• Expression upregulation: YDL183C shows a 2.141-fold increase in expression under freeze-thaw stress conditions, particularly in DaMDHAR-expressing cells with enhanced stress tolerance .

• Integration into stress response networks: Under stress conditions, YDL183C becomes functionally integrated with other stress-responsive genes including FMP16, PHM7, MSC1, NQM1, CTT1, and ALD3, which form the central core of the genetic stress response network .

• Metabolic adaptation: YDL183C upregulation correlates with changes in NADPH concentration and activation of multiple redox-related enzymes including aldehyde dehydrogenases (ALD3, ALD4, ALD6) and catalase (CTT1) .

• Mitochondrial integrity maintenance: As part of the mitochondrial KHE system, YDL183C likely contributes to maintaining ion homeostasis across mitochondrial membranes during oxidative stress, preventing mitochondrial swelling and dysfunction.

• Reduced mitochondrial death effector activation: YDL183C upregulation coincides with downregulation of mitochondrial cell death effectors like AIF1 (0.485-fold) , suggesting a protective role in preventing apoptotic cascades during stress.

The shift in YDL183C function appears to be regulated through stress-responsive transcription factors including MSN4 and CIN5, which were also upregulated under the same conditions (2.061-fold and 3.522-fold, respectively) .

How can YDL183C antibodies be used to study the relationship between mitochondrial function and oxidative stress response?

YDL183C antibodies offer powerful tools for investigating the mitochondria-oxidative stress relationship through several sophisticated approaches:

• Proximity labeling proteomics: Conjugate YDL183C antibodies to proximity labeling enzymes (BioID or APEX2) to identify stress-induced proximity interactions within the mitochondrial network.

• Super-resolution microscopy: Employ fluorescently-labeled YDL183C antibodies in techniques like STORM or PALM to visualize nanoscale changes in mitochondrial organization during oxidative stress.

• Mitochondrial dynamics analysis: Combine YDL183C antibody labeling with mitochondrial membrane potential dyes to correlate YDL183C localization with functional status of mitochondria during stress.

• Multiplexed immunohistochemistry: Simultaneously detect YDL183C alongside other proteins in the identified network (CTT1, ALD3, etc.) to map spatial relationships during stress response.

• Flow cytometry: Use fluorescently-labeled YDL183C antibodies in conjunction with ROS-sensitive dyes to correlate YDL183C expression with cellular ROS levels at single-cell resolution.

• In situ proximity ligation assay (PLA): Detect interactions between YDL183C and other mitochondrial proteins that change during oxidative stress conditions.

• Cryo-immunoelectron microscopy: Precisely localize YDL183C within mitochondrial subcompartments during normal and stress conditions with nanometer resolution.

These advanced techniques leverage YDL183C antibodies to provide mechanistic insights into how mitochondria respond to and mitigate oxidative damage.

What are the challenges in detecting post-translational modifications of YDL183C?

Detecting post-translational modifications (PTMs) of YDL183C presents several technical challenges that require specialized approaches:

• Low abundance of modified forms: PTMs often occur on only a small fraction of the total protein pool, necessitating enrichment strategies such as phosphopeptide enrichment (TiO₂ or IMAC) for phosphorylated forms or ubiquitin remnant motif antibodies for ubiquitinated forms.

• Mitochondrial localization complexity: The mitochondrial location of YDL183C creates additional extraction challenges, as some PTMs may be lost during conventional mitochondrial isolation procedures due to phosphatase or protease activity.

• PTM-specific antibody development: Creating antibodies that specifically recognize modified YDL183C requires careful design of modified peptide antigens that accurately represent the native modification context.

• Mass spectrometry challenges: The membrane-associated nature of YDL183C presents challenges for MS-based PTM detection, often requiring specialized digestion protocols (e.g., chymotrypsin in addition to trypsin) and hydrophobic peptide enrichment.

• Dynamic regulation: Many stress-induced PTMs are highly dynamic, necessitating precise temporal sampling and rapid sample processing with appropriate inhibitors.

• Multiple modification sites: YDL183C likely contains multiple potential modification sites that may exhibit combinatorial patterns, requiring sophisticated bioinformatic analyses to interpret their functional significance.

• Functional validation: Beyond detection, determining the functional significance of identified PTMs requires site-directed mutagenesis approaches combined with stress response assays to correlate modifications with protein function.

These challenges necessitate integrating multiple complementary approaches to comprehensively characterize YDL183C's modification landscape.

How should I interpret changes in YDL183C expression in relation to other mitochondrial genes?

Interpreting YDL183C expression changes requires contextual analysis within the broader mitochondrial gene network:

• Co-expression patterns: Analyze whether YDL183C expression changes correlate with other mitochondrial genes. In stress studies, YDL183C upregulation (2.141-fold) occurred alongside other mitochondrial genes including ALD4 (4.982-fold), CRC1 (4.597-fold), GEM1 (2.403-fold), and NDE2 (2.403-fold) . Strong correlation suggests coordinated regulation within mitochondrial stress response pathways.

• Functional clustering: Interpret YDL183C changes within functional clusters identified through network analysis. The positioning of YDL183C within networks containing stress-responsive genes like CTT1 and ALD3 suggests its role in the stress response core machinery .

• Temporal dynamics: Consider the timing of YDL183C expression changes relative to other genes. Early-responding genes may be regulatory, while later changes often represent downstream effectors.

• Quantitative relationships: Examine whether YDL183C expression changes are proportional to changes in other mitochondrial genes or whether it shows unique regulation patterns.

• Opposing expression patterns: Note genes showing inverse expression patterns to YDL183C, such as the downregulated mitochondrial thioredoxin TRX3 (0.418-fold) and cytochrome c oxidase subunit COX2 (0.371-fold) , which may represent compensatory or antagonistic relationships.

• Transcription factor binding: Correlate YDL183C expression with changes in transcription factors like CIN5 (3.522-fold) and MSN4 (2.061-fold) that may directly regulate its expression.

This integrated analysis provides a systems-level interpretation of YDL183C's role within mitochondrial stress response networks.

What are common troubleshooting issues when working with YDL183C antibodies?

When working with YDL183C antibodies, researchers commonly encounter several technical challenges:

• Weak signal detection: Often caused by low YDL183C abundance in total cell lysates. Solution: Perform mitochondrial enrichment before analysis or increase protein loading (from standard 20μg to 40-50μg) .

• Multiple bands on Western blots: May represent post-translational modifications or degradation products. Solution: Include protease inhibitors during sample preparation and compare band patterns with predicted molecular weights.

• Background noise: Particularly problematic with mitochondrial proteins due to hydrophobic nature. Solution: Optimize blocking conditions (try 3-5% BSA instead of milk) and increase washing stringency with higher TBST concentrations.

• Inconsistent results between experiments: Often due to variability in stress induction. Solution: Standardize stress protocols and include positive controls (e.g., known stress-responsive proteins like CTT1) .

• Antibody cross-reactivity: May detect related mitochondrial proteins. Solution: Validate with knockout controls and perform competitive blocking with recombinant protein.

• Poor reproducibility in co-immunoprecipitation: Often due to transient interactions. Solution: Consider crosslinking approaches to stabilize protein complexes before extraction.

• Degradation during storage: YDL183C may be susceptible to degradation. Solution: Aliquot samples, avoid freeze-thaw cycles, and add protease inhibitors freshly before each experiment.

• Batch-to-batch antibody variability: Solution: Validate each new antibody lot against previous lots using standardized positive controls.

Maintaining detailed records of optimization efforts will help establish reliable protocols for consistent YDL183C detection across experiments.

How can I differentiate between direct and indirect effects on YDL183C in stress response studies?

Differentiating direct versus indirect effects on YDL183C in stress response studies requires systematic analytical approaches:

• Temporal resolution studies: Track YDL183C expression changes at fine time intervals after stress induction. Early changes (minutes to hours) are more likely direct effects, while delayed responses (hours to days) often represent secondary adaptations.

• Transcription inhibition: Perform stress experiments in the presence of transcription inhibitors (e.g., 1,10-phenanthroline in yeast). Persistent YDL183C changes despite blocked transcription suggest post-transcriptional regulation.

• Translation inhibition: Similarly, using cycloheximide to block translation can help distinguish direct post-translational modifications from effects requiring new protein synthesis.

• Transcription factor mutants: Conduct experiments in strains lacking stress-responsive transcription factors like MSN4 or CIN5 . Persistent YDL183C regulation in these backgrounds suggests transcription factor-independent mechanisms.

• Promoter analysis: Use reporter constructs with YDL183C promoter to identify stress-responsive elements and the transcription factors that bind them.

• Pathway inhibitors: Systematically inhibit known stress signaling pathways (e.g., MAPK cascades) to identify which pathways directly regulate YDL183C.

• Direct binding studies: Use techniques like ChIP to demonstrate direct binding of transcription factors to the YDL183C promoter under stress conditions.

• Genetic epistasis analysis: Position YDL183C within stress response pathways through double-mutant analysis with upstream and downstream components.

This multilayered approach provides mechanistic understanding of how YDL183C is regulated within stress response networks, distinguishing primary regulatory events from secondary adaptations.

Reference Table: Stress-Responsive Genes Related to YDL183C Function

The following table summarizes key genes functionally related to YDL183C in stress response networks: